Skip to main content
Fig. 1 | Addiction Science & Clinical Practice

Fig. 1

From: Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach

Fig. 1

Buprenorphine/naloxone microdosing regimen (daily witness ingestion). The team partnered with a local pharmacy who were able to split that tablets for microdosing. The tablet splitting may not have been 100% accurate, however it was effective for this patient, given that the technique is to start low and gradually increase and best practice for dosing has yet to be established

Back to article page